1.
Antitumoral effects of 9-cis retinoic acid in adrenocortical cancer
by Szabó, Diana Rita
Cellular and molecular life sciences : CMLS, 2013, Vol.71 (5), p.917-932
2.
Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas
by Piunti, Andrea
Nature medicine, 2017, Vol.23 (4), p.493-500
3.
Activation of insulin-like growth factor 1 receptor regulates the radiation-induced lung cancer cell apoptosis
by Zhang, Heng
Immunobiology (1979), 2015, Vol.220 (10), p.1136-1140
4.
Targetable long non-coding RNAs in cancer treatments
by Chen, Liang
Cancer letters, 2018, Vol.418, p.119-124
5.
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
by Balachandran, Vinod P
Nature medicine, 2011, Vol.17 (9), p.1094-1100
6.
Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90
by Moulick, Kamalika
Nature chemical biology, 2011, Vol.7 (11), p.818-826
7.
Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma
by Ambrogio, Chiara
Nature medicine, 2016, Vol.22 (3), p.270-277
8.
Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155
by Chang, Suhwan
Nature medicine, 2011, Vol.17 (10), p.1275-1282
9.
Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop
by Aceto, Nicola
Nature medicine, 2012, Vol.18 (4), p.529-537
11.
Long non-coding RNA MALAT1 modulates radiosensitivity of HR-HPV+ cervical cancer via sponging miR-145
by Lu, Hongzhi
Tumor biology, 2015, Vol.37 (2), p.1683-1691
12.
Determinants of resistance to chemotherapy and ionizing radiation in breast cancer stem cells
by Pavlopoulou, Athanasia
Cancer letters, 2016, Vol.380 (2), p.485-493
13.
CDKN2A Loss Is Associated With Shortened Overall Survival in Lower-Grade (World Health Organization Grades II–III) Astrocytomas
by Reis, Gerald F
Journal of neuropathology and experimental neurology, 2015, Vol.74 (5), p.442-452
14.
Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition
by Johnson, Neil
Nature medicine, 2011, Vol.17 (7), p.875-882
15.
ERK activation drives intestinal tumorigenesis in Apc(min/+) mice
by Lee, Sung Hee
Nature medicine, 2010, Vol.16 (6), p.665-670
16.
Adaptation to Oxidative Stress, Chemoresistance, and Cell Survival
by Landriscina, Matteo
Antioxidants & redox signaling, 2009, Vol.11 (11), p.271-2716
17.
Rational therapeutic combinations with histone deacetylase inhibitors for the treatment of cancer
by Thurn, K Ted
Future oncology (London, England), 2011, Vol.7 (2), p.263-283
18.
Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer
by Chang, Jenny C
The Lancet (British edition), 2003, Vol.362 (9381), p.362-369
19.
20.
Unmasking the Lung Cancer Epigenome
by Belinsky, Steven A
Annual review of physiology, 2015, Vol.77 (1), p.453-474
